Home Featured


Ex-Blue Wolf investor Michael Ranson is focusing on what matters the most, and it’s not raising capital.
Joining forces on a clinical study to improve neonatal outcomes, the partnership illustrates Blue Ox's strategy of backing innovations that both lower healthcare costs and improve patient outcomes.
Firms continue to rank talent management and asset growth as the top two strategic priorities, while making little progress in representation, a new EY survey reveals.
Leveraging a long-term relationship, the PE firm buys a $450 million car parts distributor.
Jim Momtazee’s new healthcare-focused private equity firm grows its team to five, adding former KKR and Ares investors as founding partners.
Century Park Capital Partners, Cirtec, medical devices, healthcare, private equity, merger, M&A
Corza Medical snaps up Surgical Specialties and merges it with TachoSil - a carve-out from Japan's Takeda - to create a $300 million-plus revenue generating surgical technologies company.
Evercore is mandated to advise the company on its sale, which is expected to kick off in a few weeks, sources familiar with the matter said.
clinical research, clinical trial, medical, greenphire, lab
Greenphire, expected to hit the block in April, ought to command dual interest from growth-oriented financial sponsors and a wide pool of strategic buyers, sources told PE Hub.
D. Scott Mackesy
Following a great year at WCAS – with $1.6 billion worth of distributions and some $1.5 billion in new investment – the managing partner remains worried about work-life balance, relationship development and the continuing fallout from the pandemic.
In the new role, Kevin Lawi will work with leading private equity sponsors and corporates to target opportunities across the capital structure.

Copyright PEI Media

Not for publication, email or dissemination